.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Cantor Fitzgerald
Deloitte
Boehringer Ingelheim
Federal Trade Commission
Harvard Business School
Colorcon
Johnson and Johnson
Moodys

Generated: June 24, 2017

DrugPatentWatch Database Preview

MINOCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Minocin, and when can generic versions of Minocin launch?

Minocin is a drug marketed by Triax Pharms, Lederle, Rempex Pharms Inc, and Precision Dermat. and is included in five NDAs. There are two patents protecting this drug.

This drug has twenty patent family members in nineteen countries.

The generic ingredient in MINOCIN is minocycline hydrochloride. There are thirteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Summary for Tradename: MINOCIN

Patents:2
Applicants:4
NDAs:5
Suppliers / Packagers: see list4
Bulk Api Vendors: see list74
Clinical Trials: see list29
Patent Applications: see list1,533
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MINOCIN at DailyMed

Pharmacology for Tradename: MINOCIN

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Triax Pharms
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050315-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Precision Dermat
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050649-001May 31, 1990ABRXNoNo► Subscribe► Subscribe
Rempex Pharms Inc
MINOCIN
minocycline hydrochloride
INJECTABLE;INJECTION050444-001Approved Prior to Jan 1, 1982RXYesYes9,084,802► Subscribe ► Subscribe
Precision Dermat
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050649-003Feb 12, 2001DISCNYesNo► Subscribe► Subscribe
Triax Pharms
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050315-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MINOCIN

Country Document Number Estimated Expiration
China102970992► Subscribe
European Patent Office2568987► Subscribe
Japan2016145253► Subscribe
Hong Kong1180586► Subscribe
Mexico2012012993► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Colorcon
US Army
McKinsey
Teva
Federal Trade Commission
Argus Health
Deloitte
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot